Tyler Stone Wealth Management Novo Nordisk A S Transaction History

Tyler Stone Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $39,512 - $47,305	-322 Reduced 45.67%	383 $54,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $42,171 - $56,134	413 Added 141.44%	705 $90,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $13,277 - $29,132	146 Added 100.0%	292 $27,000
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $8,266 - $9,150	53 Added 56.99%	146 $24,000
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $309 - $365	3 Added 3.33%	93 $10,000
Q4 2021 Feb 22, 2022	BUY	$95.88 - $117.08 $8,629 - $10,537	90 New	90 $10,000

1,870

317M

5.49M

7.77M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Tyler Stone Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Tyler Stone Wealth Management with notifications on news.